Skip to content

Centennial Wealth Advisory LLC: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Centennial Wealth Advisory LLC on CVS, newest first. How the timeline and the estimate are built.

Centennial Wealth Advisory LLC held 7,391 CVS shares at 2026-06-30 per its 13F-HR filed 2026-07-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,391 shares
    Change vs previous 13F -2,301 shares

    0.17% of the 13F portfolio, value $764,609.

    13F-HR 0002085853-26-000705 filed by Centennial Wealth Advisory LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 9,692 shares
    Change vs previous 13F +2,081 shares

    0.17% of the 13F portfolio, value $696,069.

    13F-HR 0002085853-26-000414 filed by Centennial Wealth Advisory LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 7,611 shares
    Change vs previous 13F -241 shares

    0.16% of the 13F portfolio, value $604,085.

    13F-HR 0002085853-26-000035 filed by Centennial Wealth Advisory LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 7,852 shares
    Change vs previous 13F +336 shares

    0.16% of the 13F portfolio, value $592,003.

    13F-HR 0002085853-25-000125 filed by Centennial Wealth Advisory LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 7,516 shares
    Change vs previous 13F not available

    0.16% of the 13F portfolio, value $518,521.

    13F-HR 0001667731-25-000865 filed by Centennial Wealth Advisory LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).